NCT07137182

Brief Summary

The main purpose of this study was to reveal the self-worth perceptions of women who regularly participate in physical activity and to investigate the effect of physical activity on self-worth perception and cardiovascular risk awareness.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 7, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 22, 2025

Completed
24 days until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

2 months

First QC Date

August 7, 2025

Last Update Submit

August 22, 2025

Conditions

Keywords

cardiovascular riskphysical activitiesself worth

Outcome Measures

Primary Outcomes (2)

  • Female Physical Active Self-Esteem Scale

    The Women's Physical Activity Self-Esteem Scale, developed by Huberty et al. (22) and validated and validated in Turkish by Yurtçiçek Ergüntop and Kömürcü (23), was used to measure women's physical activity self-esteem. The scale's Cronbach's alpha (0.91) and split-half value (0.74) were above 0.70, indicating reliability. The scale consists of a total of 37 items.

    8 weeks

  • Cardiovascular Disease Risk Awareness Assessment Scale

    The 26-item shortened version of the scale was adapted by Woringer et al., and the Turkish validity and reliability study was conducted by Doğru et al. (24,25). The scale consists of three sub-dimensions (perceived heart attack/stroke risk, perceived benefits and intentions to change, and healthy eating intentions).

    8 weeks

Study Arms (2)

Deney

EXPERIMENTAL

group to be included in the application

Other: 8-week physical activity program

kontrol

NO INTERVENTION

no intervention will be made

Interventions

Individuals in the experimental group will be administered an eight-week physical activity program. The researcher who will administer the activity is a specialist in Sports Sciences and holds the necessary certifications. The activity program includes cardio exercises, jumping, stretching, and stretching exercises.

Deney

Eligibility Criteria

Age18 Weeks+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsKadın
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years of age
  • Voluntarily participating in the study
  • Being female

You may not qualify if:

  • Having any physical disability,
  • Having had an injury or accident,
  • Being pregnant or having recently given birth,
  • Having a cognitive impairment that would prevent completing the survey and maintaining communication,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Motor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Hatice YAĞCI KARAMANLI

    KARAMANOĞLU MEHMETBEY UNİVERSTY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hatice YAĞCI KARAMANLI

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The statistician who will perform the analyses will be blinded.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The type of this study is a randomized controlled trial with a pre-test post-test model, including experimental and control groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 7, 2025

First Posted

August 22, 2025

Study Start

September 15, 2025

Primary Completion

November 21, 2025

Study Completion

February 1, 2026

Last Updated

August 29, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Consent to share data was not obtained from all co-authors.